News
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer: Shanghai Wednesday, July 23, 2025, 14:30 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback